Comparative Study
doi: 10.1016/0732-8893(93)90113-l.
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci
Affiliations
- PMID: 8477576
- DOI: 10.1016/0732-8893(93)90113-l
Item in Clipboard
Comparative Study
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci
Diagn Microbiol Infect Dis.
1993 Mar-Apr.
Abstract
To assess the potential clinical utility of RP 59500, 10 investigators from separate locations in the United States and Canada each tested approximately 200 current isolates of staphylococci (Staphylococcus aureus and coagulase-negative staphylococci) by a standard protocol. RP 59500 was highly active (MIC90 < or = 2 micrograms/ml) against all strains, including those that were resistant to oxacillin, ciprofloxacin, erythromycin, and spiramycin.
Similar articles
-
Post-antibiotic effect of the new streptogramin RP 59500.Eur J Clin Microbiol Infect Dis. 1992 Jul;11(7):642-5. doi: 10.1007/BF01961676. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1396777
-
In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies.J Antimicrob Chemother. 1992 Jul;30 Suppl A:59-65. doi: 10.1093/jac/30.suppl_a.59. J Antimicrob Chemother. 1992. PMID: 1399952
-
Evaluation of new agglutination test for identification of oxacillin-susceptible and oxacillin-resistant Staphylococcus aureus.J Clin Microbiol. 1995 May;33(5):1333-4. doi: 10.1128/jcm.33.5.1333-1334.1995. J Clin Microbiol. 1995. PMID: 7615750 Free PMC article.
-
In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.J Antimicrob Chemother. 1992 Jul;30 Suppl A:15-8. doi: 10.1093/jac/30.suppl_a.15. J Antimicrob Chemother. 1992. PMID: 1399945
-
In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.Clin Microbiol Infect. 2000 Nov;6(11):608-12. doi: 10.1046/j.1469-0691.2000.00152.x. Clin Microbiol Infect. 2000. PMID: 11168064
Cited by
-
Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.Drugs. 1999 Dec;58(6):1061-97. doi: 10.2165/00003495-199958060-00008. Drugs. 1999. PMID: 10651391 Review.
-
Antimicrobial susceptibility of coagulase-negative staphylococci.Antimicrob Agents Chemother. 1994 Oct;38(10):2231-7. doi: 10.1128/AAC.38.10.2231. Antimicrob Agents Chemother. 1994. PMID: 7840550 Free PMC article. Review. No abstract available.
-
Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal.Antimicrob Agents Chemother. 2001 Sep;45(9):2662-5. doi: 10.1128/AAC.45.9.2662-2665.2001. Antimicrob Agents Chemother. 2001. PMID: 11502549 Free PMC article.
-
Quinupristin-dalfopristin.Drugs. 1996 Sep;52(3):406-15. doi: 10.2165/00003495-199652030-00006. Drugs. 1996. PMID: 8875130 Review.
-
Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.J Clin Microbiol. 1998 Apr;36(4):1020-7. doi: 10.1128/JCM.36.4.1020-1027.1998. J Clin Microbiol. 1998. PMID: 9542929 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
